KLBF — Forms strategic joint venture for API production

KLBF — Forms strategic joint venture for API production Kalbe Farma (KLBF) and its subsidiary, Global Chemindo Megatrading (GCM), have partnered with China’s Lian SGP Holding to establish a new pharmaceutical raw materials plant with an initial investment of IDR650 bn. The joint venture, named Livzon Pharma Indonesia, will focus on producing active pharmaceutical ingredients (API) and other raw materials for export and domestic markets. This collaboration aims to enhance Indonesia's pharmaceutical production capabilities, reduce import dependency, and boost the country's health resilience. (Source: Investor Daily)